166 related articles for article (PubMed ID: 17309516)
1. Carnitine deficiency provokes cisplatin-induced hepatotoxicity in rats.
Al-Majed AA
Basic Clin Pharmacol Toxicol; 2007 Mar; 100(3):145-50. PubMed ID: 17309516
[TBL] [Abstract][Full Text] [Related]
2. Propionyl-L-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model.
Al-Majed AA; Sayed-Ahmed MM; Al-Yahya AA; Aleisa AM; Al-Rejaie SS; Al-Shabanah OA
Pharmacol Res; 2006 Mar; 53(3):278-86. PubMed ID: 16436331
[TBL] [Abstract][Full Text] [Related]
3. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
[TBL] [Abstract][Full Text] [Related]
4. Progression of cisplatin-induced nephrotoxicity in a carnitine-depleted rat model.
Sayed-Ahmed MM; Eissa MA; Kenawy SA; Mostafa N; Calvani M; Osman AM
Chemotherapy; 2004 Oct; 50(4):162-70. PubMed ID: 15347908
[TBL] [Abstract][Full Text] [Related]
5. Carnitine esters prevent oxidative stress damage and energy depletion following transient forebrain ischaemia in the rat hippocampus.
Al-Majed AA; Sayed-Ahmed MM; Al-Omar FA; Al-Yahya AA; Aleisa AM; Al-Shabanah OA
Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):725-33. PubMed ID: 16895547
[TBL] [Abstract][Full Text] [Related]
6. Progression of diethylnitrosamine-induced hepatic carcinogenesis in carnitine-depleted rats.
Al-Rejaie SS; Aleisa AM; Al-Yahya AA; Bakheet SA; Alsheikh A; Fatani AG; Al-Shabanah OA; Sayed-Ahmed MM
World J Gastroenterol; 2009 Mar; 15(11):1373-80. PubMed ID: 19294768
[TBL] [Abstract][Full Text] [Related]
7. Carnitine deficiency aggravates cyclophosphamide-induced cardiotoxicity in rats.
Fatani AG; Darweesh AQ; Rizwan L; Aleisa AM; Al-Shabanah OA; Sayed-Ahmed MM
Chemotherapy; 2010; 56(1):71-81. PubMed ID: 20299794
[TBL] [Abstract][Full Text] [Related]
8. Carnitine deficiency: a possible risk factor in paracetamol hepatotoxicity.
Arafa HM
Arch Toxicol; 2009 Feb; 83(2):139-50. PubMed ID: 18597074
[TBL] [Abstract][Full Text] [Related]
9. Carnitine deficiency and oxidative stress provoke cardiotoxicity in an ifosfamide-induced Fanconi Syndrome rat model.
Sayed-Ahmed MM; Darweesh AQ; Fatani AJ
Oxid Med Cell Longev; 2010; 3(4):266-74. PubMed ID: 20972373
[TBL] [Abstract][Full Text] [Related]
10. L-Carnitine attenuates ifosfamide-induced carnitine deficiency and decreased intramitochondrial CoA-SH in rat kidney tissues.
Sayed-Ahmed MM
J Nephrol; 2011; 24(4):490-8. PubMed ID: 21404227
[TBL] [Abstract][Full Text] [Related]
11. Increased urinary losses of carnitine and decreased intramitochondrial coenzyme A in gentamicin-induced acute renal failure in rats.
Al-Shabanah OA; Aleisa AM; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Fatani AG; Sayed-Ahmed MM
Nephrol Dial Transplant; 2010 Jan; 25(1):69-76. PubMed ID: 19737869
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver.
Martins NM; Santos NA; Curti C; Bianchi ML; Santos AC
J Appl Toxicol; 2008 Apr; 28(3):337-44. PubMed ID: 17604343
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin toxicity can be ameliorated during antioxidant L-carnitine supplementation.
Alshabanah OA; Hafez MM; Al-Harbi MM; Hassan ZK; Al Rejaie SS; Asiri YA; Sayed-Ahmed MM
Oxid Med Cell Longev; 2010; 3(6):428-33. PubMed ID: 21307642
[TBL] [Abstract][Full Text] [Related]
14. Progression of cyclophosphamide-induced acute renal metabolic damage in carnitine-depleted rat model.
Sayed-Ahmed MM
Clin Exp Nephrol; 2010 Oct; 14(5):418-26. PubMed ID: 20652348
[TBL] [Abstract][Full Text] [Related]
15. Hesperidin alleviates cisplatin-induced hepatotoxicity in rats without inhibiting its antitumor activity.
Omar HA; Mohamed WR; Arafa el-SA; Shehata BA; El Sherbiny GA; Arab HH; Elgendy AN
Pharmacol Rep; 2016 Apr; 68(2):349-56. PubMed ID: 26922538
[TBL] [Abstract][Full Text] [Related]
16. Relationship of hepatotoxicity and the target tissue dose of decabrominated diphenyl ether in subacutely exposed Wistar rats.
Ćurčić M; Tanasković S; Stanković S; Janković S; Antunović M; Djordjević S; Kilibarda V; Vučnić S; Antonijević B
Vojnosanit Pregl; 2015 May; 72(5):405-13. PubMed ID: 26165047
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin attenuates cisplatin-induced kidney and liver damage in rats.
Işeri S; Ercan F; Gedik N; Yüksel M; Alican I
Toxicology; 2007 Feb; 230(2-3):256-64. PubMed ID: 17196726
[TBL] [Abstract][Full Text] [Related]
18. Dose response effect of rutin a dietary antioxidant on alcohol-induced prooxidant and antioxidant imbalance - a histopathologic study.
Shenbagam M; Nalini N
Fundam Clin Pharmacol; 2011 Aug; 25(4):493-502. PubMed ID: 20727014
[TBL] [Abstract][Full Text] [Related]
19. Ellagic acid prevents cisplatin-induced oxidative stress in liver and heart tissue of rats.
Yüce A; Ateşşahin A; Ceribaşi AO; Aksakal M
Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):345-9. PubMed ID: 17910619
[TBL] [Abstract][Full Text] [Related]
20. Betaine supplementation mitigates cisplatin-induced nephrotoxicity by abrogation of oxidative/nitrosative stress and suppression of inflammation and apoptosis in rats.
Hagar H; Medany AE; Salam R; Medany GE; Nayal OA
Exp Toxicol Pathol; 2015 Feb; 67(2):133-41. PubMed ID: 25488130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
